Galmed Pharmaceuticals Ltd. (GLMD) Financials

GLMD Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 17.6 million 2.1 million
2023-06-30 13.3 million 2.7 million
2023-03-31 14.8 million 2.8 million
2022-12-31 16.6 million 3.1 million

GLMD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.2 million 226000
2023-06-30 -1.4 million 174000
2023-03-31 -1.7 million 297000
2022-12-31 -4.0 million 182000

GLMD Net Income

No data available :(

GLMD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 13.3 million - -
2023-06-30 9.3 million - -
2023-03-31 12.2 million - -
2022-12-31 13.8 million - 44000

GLMD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 6.2 million
2023-06-30 1.7 million
2023-03-31 1.7 million
2022-12-31 1.7 million

GLMD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 556000 912000 -
2023-06-30 - 809000 1.1 million -
2023-03-31 - 1.1 million 919000 -
2022-12-31 1000 1.4 million 1.1 million -

GLMD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - 8000
2022-12-31 - 9000

GLMD

Price: $0.39

52 week price:
0.26
7.80

Earnings Per Share: -3.02 USD

P/E Ratio: -0.13

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 176487

Ebitda: -2.7 million

Market Capitalization: 1.3 million

Links: